blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1461323

EP1461323 - COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  15.08.2014
Database last updated on 22.01.2025
Most recent event   Tooltip15.07.2016Lapse of the patent in a contracting state
New state(s): TR		published on 17.08.2016  [2016/33]
Applicant(s)For all designated states
Wellstat Therapeutics Corporation
930 Clopper Road
Gaithersburg, MD 20877 / US
[2004/40]
Inventor(s)01 / SHARMA, Shalini
211 Bristol Downs Drive
Gaithersbug, MD 20877 / US
02 / VON, Borstel, Reid, W.
8310 Fox Run
Potomac, MD 20854 / US
03 / HODGE, Kirvin, L.
8115 Mississipi Road
Laurel, MD 20724 / US
04 / BAMAT, Michael, K.
8310 Fox Run
Potomac, MD 20854 / US
 [2004/40]
Representative(s)Brierley, Anthony Paul, et al
Appleyard Lees
15 Clare Road
Halifax
HX1 2HY / GB
[2013/41]
Former [2004/40]Brierley, Anthony Paul, et al
Appleyard Lees 15 Clare Road
Halifax West Yorkshire HX1 2HY / GB
Application number, filing date02744271.412.06.2002
[2004/40]
WO2002US18388
Priority number, dateUS20010297282P12.06.2001         Original published format: US 297282 P
[2004/40]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO02100341
Date:19.12.2002
Language:EN
[2002/51]
Type: A2 Application without search report 
No.:EP1461323
Date:29.09.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 19.12.2002 takes the place of the publication of the European patent application.
[2004/40]
Type: B1 Patent specification 
No.:EP1461323
Date:09.10.2013
Language:EN
[2013/41]
Search report(s)International search report - published on:US01.07.2004
(Supplementary) European search report - dispatched on:EP11.09.2009
ClassificationIPC:C07D249/12, C07D257/00, C07C69/76, C07C59/86, C07C59/90, C07C229/00
[2004/40]
CPC:
A61K31/165 (EP,US); C07C69/76 (KR); C07B41/12 (US);
A01N37/10 (US); A61K31/192 (EP,US); A61K31/216 (EP,US);
A61K31/235 (EP,US); A61K31/41 (EP,US); A61K31/4196 (EP,US);
A61K31/44 (EP,US); A61K31/445 (EP,US); A61K31/535 (EP,US);
A61K31/54 (EP,US); A61P1/00 (EP); A61P1/16 (EP);
A61P13/00 (EP); A61P13/12 (EP); A61P17/00 (EP);
A61P17/02 (EP); A61P25/00 (EP); A61P27/00 (EP);
A61P27/02 (EP); A61P27/12 (EP); A61P3/00 (EP);
A61P3/04 (EP); A61P3/06 (EP); A61P3/08 (EP);
A61P3/10 (EP); A61P35/00 (EP); A61P43/00 (EP);
A61P5/50 (EP); A61P7/00 (EP); A61P7/12 (EP);
A61P9/00 (EP); A61P9/10 (EP); A61P9/12 (EP);
C07C209/68 (US); C07C217/22 (EP,US); C07C229/44 (KR);
C07C233/31 (EP,US); C07C233/47 (EP,US); C07C235/78 (EP,US);
C07C235/84 (EP,US); C07C259/06 (EP,US); C07C323/52 (EP,US);
C07C323/59 (EP,US); C07C59/68 (EP,US); C07C59/90 (EP,US);
C07C67/47 (US); C07C69/734 (KR); C07C69/738 (EP,KR,US);
C07D213/30 (EP,US); C07D213/55 (EP,US); C07D249/10 (EP,US);
C07D249/12 (EP,US); C07D257/04 (EP,US); C07D333/16 (EP,US);
C07D333/24 (EP,US); C07C2601/02 (EP,US); C07C2601/04 (EP,US);
C07C2602/04 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2004/40]
Extension statesAL19.08.2004
LT19.08.2004
LV19.08.2004
MK19.08.2004
RO19.08.2004
SI19.08.2004
TitleGerman:VERBINDUNGEN ZUR BEHANDLUNG VON STOFFWECHSELSTÖRUNGEN[2004/40]
English:COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS[2004/40]
French:COMPOSES DESTINES AU TRAITEMENT DE TROUBLES METABOLIQUES[2004/40]
Entry into regional phase09.01.2004National basic fee paid 
09.01.2004Search fee paid 
09.01.2004Designation fee(s) paid 
09.01.2004Examination fee paid 
Examination procedure09.01.2003Request for preliminary examination filed
International Preliminary Examining Authority: US
14.01.2004Examination requested  [2004/40]
19.03.2004Amendment by applicant (claims and/or description)
23.02.2011Despatch of a communication from the examining division (Time limit: M06)
11.10.2011Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
09.12.2011Reply to a communication from the examining division
12.09.2012Despatch of a communication from the examining division (Time limit: M04)
22.01.2013Reply to a communication from the examining division
03.04.2013Communication of intention to grant the patent
05.08.2013Fee for grant paid
05.08.2013Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  23.02.2011
Opposition(s)10.07.2014No opposition filed within time limit [2014/38]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
09.12.2011Request for further processing filed
09.12.2011Full payment received (date of receipt of payment)
Request granted
23.12.2011Decision despatched
Fees paidRenewal fee
09.01.2004Renewal fee patent year 03
21.06.2005Renewal fee patent year 04
28.06.2006Renewal fee patent year 05
27.06.2007Renewal fee patent year 06
25.06.2008Renewal fee patent year 07
26.06.2009Renewal fee patent year 08
25.06.2010Renewal fee patent year 09
27.06.2011Renewal fee patent year 10
26.06.2012Renewal fee patent year 11
27.08.2013Renewal fee patent year 12
Penalty fee
Additional fee for renewal fee
30.06.201312   M06   Fee paid on   27.08.2013
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT09.10.2013
BE09.10.2013
CY09.10.2013
DK09.10.2013
FI09.10.2013
MC09.10.2013
SE09.10.2013
TR09.10.2013
GR10.01.2014
PT10.02.2014
LU12.06.2014
[2016/33]
Former [2016/28]AT09.10.2013
BE09.10.2013
CY09.10.2013
DK09.10.2013
FI09.10.2013
MC09.10.2013
SE09.10.2013
GR10.01.2014
PT10.02.2014
LU12.06.2014
Former [2015/09]AT09.10.2013
BE09.10.2013
CY09.10.2013
DK09.10.2013
FI09.10.2013
MC09.10.2013
SE09.10.2013
PT10.02.2014
LU12.06.2014
Former [2014/41]AT09.10.2013
BE09.10.2013
CY09.10.2013
DK09.10.2013
FI09.10.2013
SE09.10.2013
PT10.02.2014
Former [2014/28]AT09.10.2013
BE09.10.2013
CY09.10.2013
FI09.10.2013
SE09.10.2013
PT10.02.2014
Former [2014/26]AT09.10.2013
BE09.10.2013
CY09.10.2013
FI09.10.2013
SE09.10.2013
Former [2014/24]AT09.10.2013
BE09.10.2013
FI09.10.2013
SE09.10.2013
Former [2014/23]BE09.10.2013
FI09.10.2013
SE09.10.2013
Former [2014/22]FI09.10.2013
SE09.10.2013
Documents cited:SearchJP47025149B  [ ] (TANABE SEIYAKU CO., LTD.);
 [X]FR5035M  (CARLO ERBA) [X] 1-6,15,16,18,19,95 * example 2 *;
 JPS5225734  [ ] (KYORIN SEIYAKU KK);
 JPS5515460  [ ] (HISAMITSU PHARMACEUTICAL CO);
 JPS6140270  [ ] (MORISHITA PHARMA);
 JPH04159266  [ ] (FUJISAWA PHARMACEUTICAL CO);
 [X]  - IRIKURA, TSUTOMU, "Ethyl 4-(4-chlorobenzyloxy)benzoylacetate", CA, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, Database accession no. 1977:467987, URL: STN, XP002543824 [X] 1-4,6,7,15,16,18,19,21 * abstract *
 [X]  - OKUMURA, KENTARO ET AL, "Benzoylacetanilide derivatives", CA, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, Database accession no. 1973:15845, URL: STN, XP002543825 [X] 1-4,6,15,16,18,19 * abstract *
 [X]  - BOLHOFER, WM. A., "3-(m-Hydroxyphenyl)serine and 3-(p-hydroxyphenyl)serine", CA, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, Database accession no. 1954:67977, URL: STN, XP002543826 [X] 1-4,6,15,16,18,19 * abstract *
 [X]  - NODA, KANJI ET AL, "2-(Substituted benzoyl)propionic acids", CA, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, Database accession no. 1980:471315, URL: STN, XP002543827 [X] 1-6,11-13 * abstract *
 [X]  - ISEKAWA, JUNICHI ET AL, "Phenylpyridazinone derivatives", CA, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, Database accession no. 1986:224909, URL: STN, XP002543828 [X] 1-5,11,12 * abstract *
 [X]  - MANGLA, V. K. ET AL, "Synthesis of tylophorine", CA, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, Database accession no. 1981:209019, URL: STN, XP002543829 [X] 1-4,6 * abstract *
 [X]  - FADNAVIS, N. W. ET AL, "Baker's yeast mediated enantiospecific synthesis of anti-(2R,3R)-p-chloro-3-hydroxytyrosine: an .alpha.-amino-.beta.-hydroxy acid of vancomycin", CA, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, Database accession no. 1998:45825, URL: STN, XP002543830 [X] 1-4,6 * abstract *
 [X]  - TAKASUGI, HISASHI ET AL, "Preparation of 4-imino-1,2,3,4-tetrahydropyrimidin-2-one derivatives as cardiotonic agents", CA, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, Database accession no. 1993:22247, URL: STN, XP002543831 [X] 1-4,6 * abstract *
 [X]  - VON WACEK, ANTON ET AL, "Synthesis of methoxylated compounds for a comparative investigation of the stability of methyl ether groups", CA, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, Database accession no. 1967:10685, URL: STN, XP002543832 [X] 1,2,4-6 * abstract *
International search[X]DE2309986  (MENARINI SAS);
 [X]US4098816  (THORNE DAVID EDWARD, et al);
 [X]US4638094  (NAKAI MAMORU [JP], et al);
 [X]WO9911255  (ONO PHARMACEUTICAL CO [JP], et al);
 [X]WO9920275  (RHONE POULENC RORER PHARMA [US], et al);
 [A]WO0140170  (ASTRAZENECA AB [SE], et al);
 [XE]US6555536  (BURRIS THOMAS P [US], et al);
 [A]  - WITIAK D.T. ET AL., "Synthesis of ethyl 6-substituted-chroman- and -chromone-2-carboxylates. A comparative structure-activity study employing the 6-phenyl and phenoxy analogs in the triton hyperlipidemic rat model", JOURNAL OF MEDICINAL CHEMISTRY, (1975), vol. 18, no. 9, pages 934 - 942, XP002934911

DOI:   http://dx.doi.org/10.1021/jm00243a015
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.